4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-24-009709
CEO, CFO, Director acquired 5,558 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2024-03-11 | Option exercise | +5,558 | 96,849 | D | ||
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2024-03-11 | Option exercise · Restricted Stock Units | −5,558 | 50,025 | D | ||
Loading xslF345X05/ownership.xml…